4 things to know about the worldwide stem cells market

Spinal Tech

Here are four things to know about the worldwide stem cells market:

1. In 2013, the stem cells market was valued at $26.23 billion.

 

2. The stem cells market is projected to be valued at $119.52 by 2019, growing at a compound annual growth rate of 24.2 percent.

 

3. The stem cells market can be fragmented based on:

 

•    Product —  The market is divided into adult stem cell, rat neural stem cell, human embryonic stem cell, induced pluripotent stem cell and very small embryonic-like stem cell.
•    Application — Stem cells are categorized as drug discovery and development as well as regenerative medicine
•    Technology — The market is divided into stem cell expansion and sub-culture, stem cell cryopreservation, stem cell acquisition and stem cell production.
•    Geography — The market is divided into North America, Europe, Asia-Pacific and the rest of the world

 

4. The key companies in the worldwide stem cells market include California Stem Cell, Cellular Engineering Technologies, Biotime, Brainstorm Cell Therapeutics, Cytori Therapeutics, Celgene, Bioheart, Cellartis AB, Osiris Therapeutics, Angel Biotechnology, Advanced Cell Technology and Stemcelltechnologies.

 

More articles on devices:
5 key notes on Stryker stock after director sells another 12k shares
SeaSpine launches Ventura NanoMetalene spine device: 5 key points
NuVasive to take part in investor event: 4 key notes

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers